Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Comandini

Showing results (151-160 of 233) with videos related to

Pageof 24
Sort By:
AIDS (London, England)|June 17, 2005
Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patientsMauro Zaccarelli, Valerio Tozzi, Patrizia Lorenzini, et al.
Viruses|August 8, 2017
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral AgentsBarbara Bartolini, Emanuela Giombini, Chiara Taibi, et al.
Medicine|October 8, 2020
The impact of the coronavirus disease 2019 pandemic on a central Italy transplant centerMarzia Montalbano, Giovanni Battista Levi Sandri, Ubaldo Visco Comandini, et al.
Appetite|November 10, 2022
Food-related aversion in a female sample of people with anorexia nervosa: Cognitive-behavioural correlates, somatic and subjective anxiety, and early experiencesCarolina Simonazzi, Ludovica Natali, Lucia Valmaggia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factorsValerio Tozzi, Pietro Balestra, Rita Bellagamba, et al.
Investigational New Drugs|November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancerFrancesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Plos One|August 26, 2016
Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome PredictorsAnna Rosa Garbuglia, Ubaldo Visco-Comandini, Raffaella Lionetti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 26, 2015
The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infectionAnna Rosa Garbuglia, Raffaella Lionetti, Daniele Lapa, et al.
Frontiers in Oncology|July 2, 2021
Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case ReportDanila Comandini, Fabio Catalano, Massimiliano Grassi, et al.
Virus Research|October 15, 2017
Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replicationE Cimini, V Bordoni, A Sacchi, et al.
Pageof 24

Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
AIDS (London, England)|June 17, 2005
Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patientsMauro Zaccarelli, Valerio Tozzi, Patrizia Lorenzini, et al.
Viruses|August 8, 2017
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral AgentsBarbara Bartolini, Emanuela Giombini, Chiara Taibi, et al.
Medicine|October 8, 2020
The impact of the coronavirus disease 2019 pandemic on a central Italy transplant centerMarzia Montalbano, Giovanni Battista Levi Sandri, Ubaldo Visco Comandini, et al.
Appetite|November 10, 2022
Food-related aversion in a female sample of people with anorexia nervosa: Cognitive-behavioural correlates, somatic and subjective anxiety, and early experiencesCarolina Simonazzi, Ludovica Natali, Lucia Valmaggia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factorsValerio Tozzi, Pietro Balestra, Rita Bellagamba, et al.
Investigational New Drugs|November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancerFrancesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Plos One|August 26, 2016
Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome PredictorsAnna Rosa Garbuglia, Ubaldo Visco-Comandini, Raffaella Lionetti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 26, 2015
The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infectionAnna Rosa Garbuglia, Raffaella Lionetti, Daniele Lapa, et al.
Frontiers in Oncology|July 2, 2021
Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case ReportDanila Comandini, Fabio Catalano, Massimiliano Grassi, et al.
Virus Research|October 15, 2017
Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replicationE Cimini, V Bordoni, A Sacchi, et al.
Pageof 24